Health ❯ Healthcare ❯ Pharmaceuticals

Weight Loss

GLP-1 Drugs Wegovy Mounjaro GLP-1 Medications Obesity Treatments Semaglutide Clinical Trials GLP-1 Receptor Agonists Obesity Treatment Orforglipron Ozempic Tirzepatide GLP-1 Agonists Medications Injections GLP-1 Treatments Compounded Medications Compounded Drugs Medication Weight Loss Injections Weight Loss Drugs Prescription Drugs Eli Lilly GLP-1 Therapies CagriSema Zepbound Amycretin Obesity Drugs Novo Nordisk Obesity Medication Efficacy Market Availability Orforpligron Celebrity Endorsements Mounjaro (Tirzepatide) Ecnoglutida Drug Development CargriSema Accessibility Pricing Orforgilpron Injectable Drugs GLP Agonist Drugs Drug Approval Amylin Analogs Medical Incidents Unapproved Drugs Semaglutide Injection Prescription Medications Drug Competition Eloralintide Regulatory Issues Tirzepatida AI-Generated Content Medication Switching Generic Drugs Microdosing Oral Medications Regulation of Medicines Advertising Anti-Obesity Medications Illegal Drugs GLP-1 and GIP Drugs Slimming Injections Hormonal Treatments Drug Trials Drug Pricing GLP-1 Injections Online Purchases Drug Efficacy Cagrisema Drug Comparison Anti-Obesity Drugs Ozempic and Wegovy Weight Loss Pills Adverse Reactions Muscle Health

India Poised for Semaglutide Generics as Patent Expires, Prices Expected to Plunge

Regulators tighten promotion rules to steer safe use during the market shift.

Lilly’s Oral GLP-1 Orforglipron Tops Oral Semaglutide in Lancet Phase 3 Diabetes Trial

Novo’s CagriSema Falls Short of Lilly’s Tirzepatide in 84-Week Head‑to‑Head Trial

Serena Williams’ Super Bowl Ro Ad Promotes GLP-1 Weight Loss, Draws Backlash

Hims & Hers Halts $49 Compounded Wegovy Pill as FDA Tightens GLP-1 Rules

Hims Launches $49 Compounded Wegovy-Style Pill as Novo Vows Legal Action

Jefferies Model Links GLP-1 Weight Loss Use to $580 Million in Annual Airline Fuel Savings

Wegovy Pill Debuts to Strong U.S. Demand as Next‑Gen Obesity Drugs Near Decisions

New Evidence Flags Rapid Weight Regain After Stopping GLP-1 Drugs

Eli Lilly’s GLP-1 Lead Faces New Pressure From Novo’s Weight-Loss Pill

BMJ Review Flags Rapid Weight Regain After GLP‑1 Stop as UK Approves Higher‑Dose Wegovy

Amazon Pharmacy Adds FDA-Approved Wegovy Pill With $25 Copays and Nationwide Delivery

Novo Nordisk Launches Wegovy Weight‑Loss Pill in U.S. at $149 Starter Price

FDA Approves First Oral GLP-1 for Obesity as Novo’s Wegovy Pill Sets January U.S. Launch

FDA Approves Wegovy Weight-Loss Pill as First Oral GLP-1 for Obesity

Lilly’s Daily Obesity Pill Sustains Weight Loss After Switch From Wegovy or Zepbound

Novo Nordisk Files for 7.2 mg Wegovy Dose After Stronger Weight-Loss Results

Stopping GLP-1 Weight-Loss Drugs Before Pregnancy Linked to Higher Gestational Risks, Study Finds

Lancet Phase 3 Trial Shows Oral GLP-1 Orforglipron Aids Weight Loss and Diabetes Control

Novo Nordisk Slashes Wegovy Price in India by Up to 37% to Take On Mounjaro